Jason P Rhodes
CIK 1577014 · President, CFO and Treasurer · last filed 2026-06-09
Jason P Rhodes is a President, CFO and Treasurer who has filed 51 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for DYN, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$85.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $36.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$36.58M
5
51
-$85.25M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Director | 1,549,288 | $18.19 | $28.18M | -$59.77M | 17 | 2026-06-09 |
| Generation Bio Co. (GBIO) Delisted | Director | 0 | $5.34 | $0 | -$18.24M | 14 | 2026-02-09 |
| REPL | Director | 946,000 | $8.88 | $8.40M | -$2.69M | 11 | 2022-04-05 |
| Disc Medicine, Inc. (GMTX) Delisted | Director | — | $13.50 | — | $0 | 1 | 2021-10-06 |
| Epizyme, Inc. (EPZM) Delisted | President, CFO and Treasurer | 138,000 | $1.47 | $202.9K | -$4.54M | 8 | 2014-09-24 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | DYN | Grant (A) | — | $0 | EDGAR |
| 2026-05-06 | DYN | Sell (S) | −106,723 | -$1.94M | EDGAR |
| 2026-04-27 | DYN | Sell (S) | −384,549 | -$7.10M | EDGAR |
| 2026-04-22 | DYN | Sell (S) | −834,302 | -$16.48M | EDGAR |
| 2026-02-09 | Generation Bio Co. (GBIO) Delisted | Mixed | −827,946 | $0 | EDGAR |
| 2025-06-06 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | DYN | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | DYN | Grant (A) | +1,111,111 | $15.00M | EDGAR |
| 2024-11-18 | DYN | Sell (S) | −782 | -$25.9K | EDGAR |
| 2024-06-10 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |